NR1I2 and malignant colon neoplasm: We propose that this disparity may arise from the prolonged progression of CAC, where PXR plays diverse roles in the transition from inflammatory bowel disease to cancer, significantly influencing colon cancer progression, metastasis, migration and chemotherapy resistance, while being closely linked to tissue specificity, inflammatory environment and individual variabilities.39, 40, 41, 42